LeMaitre Vascular Stock Price and Value Analysis

Should you buy LeMaitre Vascular stock? (NasdaqGM:LMAT). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantages
None.
  • This company has a low dividend yield.
  • This company has wild ups and downs.
  • This company is making money at a modest rate.
  • This company is less known than others.
  • This stock looks overpriced.

LMAT Free Cash Flow Trend

Based on historical returns, we believe that LeMaitre Vascular can grow its free cash at a rate of about 1%. That's positive!

Free Cash Flow trendline for LMAT
Free Cash Flow trendline for LeMaitre Vascular

Inside the LMAT Numbers

LMAT Price
(LeMaitre Vascular stock price per share)
$27.24
[?] LMAT Fair Price
(based on intrinsic value)
$5.61
[?] LMAT Safety Price (based on a variable margin of safety) $3.37
[?] PE Ratio versus Sector 131% higher than other Healthcare stocks
[?] PE Ratio versus Industry 94% higher than other Medical Instruments & Supplies stocks
[?] Free Cash Flow Jitter 70%
[?] Dividend Yield 1%

Is LeMaitre Vascular Stock on Sale?

We believe that LeMaitre Vascular may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

LeMaitre Vascular looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy LMAT Stock?

Does LeMaitre Vascular have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.